Oxidovanadium(IV) complexes with chrysin and silibinin: Anticancer activity and mechanisms of action in a human colon adenocarcinoma model

Journal of Biological Inorganic Chemistry

Volumn 20, Issue 7, 2015, Pages 1175-1191

  Leon I E ^a,b   Cadavid Vargas, J F ^a,b   Tiscornia, I ^c   Porro, V ^c   Castelli, S ^d   Katkar, P ^d   Desideri, A ^d   Bollati Fogolin, M ^c   Etcheverry, S B ^a,b  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

^c INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Flavonoids; HT 29 human colon adenocarcinoma cells; Mechanisms of action; Metal based drug; Vanadium

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CHRYSIN; CISPLATIN; DNA TOPOISOMERASE; FLAVONOID; GLUTATHIONE; GLUTATHIONE DISULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; METAL; METAL COMPLEX; OXIDOVANADIUM CHRYSIN; OXIDOVANADIUM COMPLEX; OXIDOVANADIUM SILIBININ; SILIBININ; UNCLASSIFIED DRUG; VANADIUM; VANADIUM DERIVATIVE; COORDINATION COMPOUND; SILYMARIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER MODEL; CELL VIABILITY; COLON ADENOCARCINOMA; COMPLEX FORMATION; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVATION; G2 PHASE CELL CYCLE CHECKPOINT; HT 29 CELL LINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ADENOCARCINOMA; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; COLONIC NEOPLASMS; DRUG EFFECTS; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; COLONIC NEOPLASMS; COORDINATION COMPLEXES; FLAVONOIDS; HUMANS; MOLECULAR STRUCTURE; SILYMARIN; VANADIUM;

EID: 84943556040     PISSN: 09498257     EISSN: 14321327     Source Type: Journal    
DOI: 10.1007/s00775-015-1298-7     Document Type: Article

References (83)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) CA Cancer J Clin 61:69-90
2. Surh YJ (2003) Nat Rev Cancer 3:768-780
3. Nielsen FH (1995) In: Sigel H, Sigel A (eds) Metal ions in biological systems, vanadium and its role in life. Dekker, New York, pp 543-574
4. Srivastava K, Mehdi MZ (2004) Diabet Med 22:2-13
5. Thompson KH, Lichter J, LeBel C, Scaife MC, McNeill JH, Orvig C (2009) J Inorg Biochem 103:554-558
6. Shioda N, Han F, Fukunaga K (2009) Int Rev Neurobiol 85:375-387
7. Evangelou AM (2002) Crit Rev Oncol Hematol 42:249-265
8. Etcheverry SB, Williams PAM (2009) New developments in medicinal chemistry. In: Ortega MP, Gil IC (eds) Medicinal chemistry of copper and vanadium bioactive compounds. Nova, Hauppauge, pp 105-129
9. Barrio DA, Etcheverry SB (2010) Curr Med Chem 17:3632-3642
10. Köpf-Maier P (1987) Naturwissenschaften 74:374-382
11. Naso LG, Ferrer EG, Butenko N, Cavaco I, Lezama L, Rojo T, Etcheverry SB, Williams PA (2011) J Biol Inorg Chem 16:653-668
12. Naso LG, Ferrer EG, Lezama L, Rojo T, Etcheverry SB, Williams PA (2010) J Biol Inorg Chem 15:889-902
13. Beecher GR (2003) J Nutr 133:3248S-3254S
14. Han X, Shen T, Lou H (2007) Int J Mol Sci 8:950-988
15. Gazák R, Walterova D, Kren V (2007) Curr Med Chem 14:315-338
16. Singh RP, Agarwal R (2004) Curr Cancer Drug Targets 4:1-11
17. Hogan FS, Krishnegowda NK, Mikhailova M, Kahlenberg MS (2007) J Surg Res 143:58-65
18. Ge Y, Zhang Y, Chen Y, Li Q, Chen J, Dong Y, Shi W (2011) Int J Mol Sci 12:4861-4871
19. Koc AN, Silici S, Ayangil D, Ferahbas A, Cankay S (2005) Mycoses 48:205-210
20. Sak K (2014) Pharmacogn Rev 8:122-146
21. Yu XM, Phan T, Patel PN, Jaskula-Sztul R, Chen H (2013) Cancer 119:774-781
22. Li X, Wang JN, Huang JM, Xiong XK, Chen MF, Ong CN, Shen HM, Yang XF (2011) Toxicol In Vitro 25:630-635
23. Uivarosi V, Barbuceanu SF, Aldea V, Arama CC, Badea M, Olar R, Marinescu D (2010) Molecules 15:1578-1589
24. Thompson KH, Orvig C (2001) Coord Chem Rev 219:1033-1053
25. Rehder D, Costa Pessoa J, Geraldes CF, Castro MM, Kabanos T, Kiss T, Meier B, Micera G, Pettersson L, Rangel M (2002) J Biol Inorg Chem 7:384-396
26. Mukherjee R, Donnay EG, Radomski MA, Miller C, Redfern DA, Gericke A, Damron DS, Brasch NE (2008) Chem Commun (Camb) 32:3783-3785
27. Leon IE, Di Virgilio AL, Porro V, Muglia CI, Naso LG, William PAM, Bollati Fogolin M, Etcheverry SB (2013) Dalton Trans 42:11868-11880
28. Leon IE, Porro V, Di Virgilio AL, Naso LG, William PAM, Bollati Fogolin M, Etcheverry SB (2014) J Biol Inorg Chem 19:59-74
29. Okajima T, Nakamura K, Zhang H, Ling N, Tanabe T, Yasuda T, Rosenfeld RG (1992) Endocrinology 130:2201-2212
30. Cortizo AM, Etcheverry SB (1995) Mol Cell Biochem 145:97-102
31. Mosmann TT (1983) J Immunol Methods 65:55-63
32. Borenfreund E, Puerner JA (1984) J Tissue Cult Methods 9:7-9
33. Hissin PJ, Hilf R (1976) Anal Biochem 74:214-226
34. Gong J, Traganos F, Darzynkiewicz Z (1994) Anal Biochem 218:314-319
35. Guimarães FS, Andrade LF, Martins ST, Abud AP, Sene RV, Wanderer C, Tiscornia I, Bollati-Fogolín M, Buchi DF, Trindade ES (2010) BMC Cancer 10:113
36. Chillemi G, Fiorani P, Castelli S, Bruselles A, Benedetti P, Desideri A (2005) NucleicAcids Res 33:3339-3350
37. Jones DP, Carlson JL, Mody VC, Cai JY, Lynn MJ, Sternberg P (2000) Free Radic Biol Med 28:625-635
38. Sherr CJ (2000) Cancer Res 60:3695-3698
39. Nagata S (2000) Exp Cell Res 256:12-18
40. Hurley AA (2001) Curr Protoc Cytom 7.2.1-7.2.5
41. Pozarowski P, Grabarek J, Darzynkiewicz Z (2003) Curr Protoc Cytom 25:7.19.1-7.19.33
42. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA (1995) Nature 376:37-43
43. Sakahira H, Enari M, Nagata S (1998) Nature 391:96-99
44. Porter AG, Janicke RU (1999) Cell Death Differ 6:99-104
45. Sheikh MS, Huang Y (2003) Cell Cycle 2:550-552
46. Escárcega RO, Fuentes-Alexandro S, García-Carrasco M, Gatica A, Zamora A (2007) Clin Oncol 19:154-161
47. Sethi G, Sung B, Aggarwal BB (2008) Exp Biol Med 233:21-31
48. Oeckinghaus A, Hayden MS, Ghosh S (2011) Nat Immunol 12:695-708
49. Champoux JJ (2001) Annu NY Rev Biochem 70:369-413
50. Wang JC (1996) Ann Rev Biochem 65:635-692
51. Boege F, Straub T, Kehr A, Bosenberg C, Christiansen K, Anderson A, Jakob F, Kohrle J (1996) J Biol Chem 271:2262-2270
52. Bridewell DJ, Finlay GJ, Baguley BC (1997) Oncol Res 9:535-542
53. Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2012) Acta Biochim Pol 59:195-200
54. Djordjevic C, Wampler GL (1985) J Inorg Biochem 25:51-55
55. Bishayee A, Waghray A, Patel MA, Chatterjee M (2010) Cancer Lett 294:1-12
56. Trainer DL, Kline T, McCabe FL, Faucette LF, Field J, Chaikin M, Anzano M, Rieman D, Hoffstein S, Li DJ (1988) Int J Cancer 41:287-296
57. Lewis NA, Liu F, Seymour L, Magnusen A, Erves TR, Arca JF, Beckford FA, Venkatraman R, González-Sarrías A, Fronczek FR, Vanderveer DG, Seeram NP, Liu A, Jarrett WL, Holder AA (2012) Eur J Inorg Chem 4:664-677
58. Crans DC, Woll KA, Prusinskas K, Johnson MD, Norkus E (2013) Inorg Chem 52:12262-12275
59. Sanna D, Ugone V, Lubinu G, Micera G, Garribba E (2014) J Inorg Biochem 140:173-184
60. Crans DC, Khan AR, Mahroof-Tahir M, Mondal S, Miller SM, la Cour A, Anderson OP, Jakusch T, Kiss T (2001) J Chem Soc Dalton Trans 3337-3345
61. Sanna D, Micera G, Garribba E (2010) Inorg Chem 49:174-187
62. Willsky GR, Chi LH, Godzala M III, Kostyniak PJ, Smee JJ, Trujillo AM, Alfano JA, Ding W, Hu Z, Crans DC (2011) Coord Chem Rev 255:2258-2269
63. Rivadeneira J, Di Virgilio AL, Barrio DA, Muglia CI, Bruzzone L, Etcheverry SB (2010) Med Chem 6:9-23
64. Saxena AK, Srivastava P, Kale RK, Baquer NZ (1993) Biochem Pharmacol 45:539-542
65. Sabbioni E, Pozzi G, Devos S, Pintar A, Casella L, Fischbach M (1993) Carcinogenesis 14:2565-2568
66. Mukhtiar M, Khan MF, Jan SU, Khan H, Ullah N, Asim-ur-Rehman N (2012) Pak J Pharm Sci 25:549-553
67. Silvestri F, Ribatti D, Nico B, Silvestri N, Romito A, Dammacco F (1995) Ann Ital Med Int 10:7-13
68. Goncalves AP, Videira A, Soares P, Maximo V (2011) Life Sci 12:11-12
69. Montiel-Davalos A, Gonzalez-Villava A, Rodriguez-Lara V, Montano LF, Fortoul TI, Lopez-Marure R (2012) J Appl Toxicol 32:26-33
70. Zhao Y, Ye L, Liu H, Xia Q, Zhang Y, Yang X, Wang K (2010) J Inorg Biochem 104:371-378
71. Hosseini MJ, Seyedrazi N, Shahraki J, Pourahmad J (2012) Adv Biosci Biotechnol 3:1096-1103
72. Afeseh Ngwa H, Kanthasamy A, Anantharam V, Song C, Witte T, Houk R, Kanthasamy AG (2009) Toxicol Appl Pharmacol 240:273-285
73. Wu Y, Ma Y, Xu Z, Wang D, Zhao B, Pan H, Wang J, Xu D, Zhao X, Pan S, Liu L, Dai W, Jiang H (2014) Cancer Lett 351:108-116
74. Ray RS, Rana B, Swami B, Venu V, Chatterjee M (2006) Chem Biol Interact 163:239-247
75. Fu Y, Wang Q, Yang XG, Yang XD, Wang K (2008) J Biol Inorg Chem 13:1001-1009
76. Garg A, Aggarwal BB (2002) Leukemia 16:1053-1068
77. Mantovani A, Marchesi F, Portal C, Allavena P, Sica A (2008) Adv Exp Med Biol 610:112-127
78. Linnewiel-Hermoni K, Motro Y, Miller Y, Levy J, Sharoni Y (2014) Free Radic Biol Med 75:105-120
79. Divya CS, Pillai MR (2006) Mol Carcinog 45:320-332
80. Micheau O, Tschopp J (2003) Cell 114:181-190
81. Mo XM, Chen ZF, Qi X, Li XT, Li J (2012) Bioinorg Chem Appl 75:63-74
82. Katkar P, Coletta A, Castelli S, Sabino GL, Couto RA, Ferreira AM, Desideri A (2014) Metallomics 6:117-125
83. Chew ST, Lo KM, Lee SK, Heng MP, Teoh WY, Sim KS, Tan KW (2014) Eur J Med Chem 76:397-407